Genmab — Marts 2025
-
Mange tak for artiklen - også til at forstå for os, der ikke er specialister på området. I min download sluttede det desværre med side 3 - synes at se, at der var yderligere i artiklen. Men mange tak .
-
@Helge - tilslutter mig Pensionistens tak for artiklen som er tilgængelig for almindelige dødelige. Mangler der en side ??
Mange indlæg er rent "gobbledygook" hvis man ikke er i branchen. Kan fornemmelsen af "lukket selskab" være medvirkende til manglende perspektiv/frafald ? -
we may be trading at a 5 year low, but at least we won a price. 'yay'
https://www.bio-itworld.com/news/2025/03/19/bio-it-world-names-innovative-practices-winners -
-
Godmorgen
-
Pensionisten og NP.....Artiklen er åben for afsnittet med Genmab. Resten kræver abonnement.
-
@sukkeralf netop. Den lå klar i skuffen.
-
a ffew examples by Abbvie https://www.jonesday.com/en/practices/experience/2024/09/abbvie-alleges-former-scientist-and-his-new-employer-stole-trade-secrets-relating-to-brutons-tyrosine-kinase-btk-degrade https://www.jonesday.com/en/practices/experience/2023/12/abbvie-sues-former-scientist-and-his-new-employer-for-trade-secret-misappropriation-involving-adcs https://www.biospace.com/abbvie-legal-complaint-alleges-alvotech-misappropriated-humira-trade-secrets
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind